Non-myeloablative regimen consisting of busulfan, fludarabine, and ATG for allogeneic peripheral blood stem cell transplantation.

被引：0
|
作者：
Mayer, J [1 ]
Koristek, Z [1 ]
Krahulová, M [1 ]
Vorlicek, J [1 ]
机构：
[1] Masaryk Univ Hosp, Brno, Czech Republic
来源：
EXPERIMENTAL HEMATOLOGY | 1999年 / 27卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
361
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [11] Fludarabine and anti thymocyte globulin (ATG) as a preparative regimen for non myeloablative peripheral stem cell transplantation in multiple myeloma patients relapsing post autologous transplantation.
    Kiss, TL
    Stewart, AK
    Lipton, J
    Xu, WM
    Messner, HA
    BLOOD, 1999, 94 (10) : 358B - 358B
  • [12] An improved outcome of acute GVHD following non-myeloablative peripheral blood stem cell transplantation.
    Fahmy, OA
    Mahmoud, HK
    Haddad, A
    El Badawy, S
    Kamel, A
    Sedky, H
    Latif, SA
    Moaty, MA
    Fattah, RA
    Sobhy, A
    Nassar, A
    El Emary, M
    Rabie, T
    Adel, N
    BLOOD, 2001, 98 (11) : 356B - 356B
  • [13] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Sohn, S. K.
    Chae, Y. S.
    Kim, J. G.
    Cho, Y. Y.
    Moon, J. H.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Yang, D. H.
    Lee, J. J.
    Kim, Y. K.
    Kim, H. J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S203 - S204
  • [14] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Chae, Y. S.
    Sohn, S. K.
    Kim, J. G.
    Cho, Y. Y.
    Moon, J. H.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Yang, D. H.
    Lee, J-J
    Kim, Y-K
    Kim, H-J
    BONE MARROW TRANSPLANTATION, 2007, 40 (06) : 541 - 547
  • [15] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Y S Chae
    S K Sohn
    J G Kim
    Y Y Cho
    J H Moon
    H J Shin
    J S Chung
    G J Cho
    D H Yang
    J-J Lee
    Y-K Kim
    H-J Kim
    Bone Marrow Transplantation, 2007, 40 : 541 - 547
  • [16] Infections after allogeneic haematopoietic stem cell transplantation with a non-myeloablative conditioning regimen
    Frere, P
    Baron, F
    Bonnet, C
    Hafraoui, K
    Pereira, M
    Willems, E
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2005, 35 : S164 - S164
  • [17] Analysis of immune reconstitution in adults undergoing non-myeloablative allogeneic peripheral blood stem cell transplantation
    Guo, HF
    Qiao, ZH
    Su, LP
    Zhu, L
    Wang, HW
    Ma, LM
    HAEMATOLOGICA, 2003, 88 (07) : 833 - 835
  • [18] Red blood cell and reticulocyte chimerism studies in non-myeloablative allogeneic peripheral blood haematopoietic stem cell transplantation
    Harritshoj, L
    Berkowicz, A
    Petersen, SL
    Madsen, HO
    Ryder, LP
    Vindelov, L
    Andersen, P
    Dickmeiss, E
    BONE MARROW TRANSPLANTATION, 2004, 33 : S116 - S117
  • [19] Hemorrhagic toxoplasmosis after non-myeloablative condotioning therapy and allogeneic stem cell transplantation.
    Fuchs, M
    Stenzel, W
    Scheid, C
    Sasse, S
    Holtick, U
    Diehl, V
    Waldschmidt, DT
    BLOOD, 2002, 100 (11) : 438B - 438B
  • [20] Allogenic stem cell transplantation after non-myeloablative conditioning regimen ("mini-allogeneic" stem cell transplantation)
    Milpied, N
    PATHOLOGIE BIOLOGIE, 2002, 50 (01): : 42 - 44
12345